Eli Lilly’s most recent trend suggests a bullish bias. One trading opportunity on Eli Lilly is a Bull Put Spread using a strike $272.50 short put and a strike $267.50 long put offers a potential 38.89% return on risk over the next 22 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $272.50 by expiration. The full premium credit of $1.40 would be kept by the premium seller. The risk of $3.60 would be incurred if the stock dropped below the $267.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Eli Lilly is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Eli Lilly is bullish.
The RSI indicator is at 72.11 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Eli Lilly
Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know
Tue, 28 Dec 2021 23:00:11 +0000
Eli Lilly (LLY) closed the most recent trading day at $276.43, moving -0.71% from the previous trading session.
3 Dividend Stocks That Soared More Than 50% in 2021 and Are Still Great Buys
Sun, 26 Dec 2021 10:55:00 +0000
The dividends for such stocks are pretty much their only attraction. On the other hand, you can find dividend stocks that are anything but boring and stodgy. Here are three dividend stocks that soared more than 50% in 2021 and are still great buys.
Pioneer Series Trust Xi Buys Progressive Corp, The Walt Disney Co, Autodesk Inc, Sells Meta …
Sat, 25 Dec 2021 18:38:02 +0000
Investment company Pioneer Series Trust Xi (Current Portfolio) buys Progressive Corp, The Walt Disney Co, Autodesk Inc, Wells Fargo, Qualcomm Inc, sells Meta Platforms Inc, Amphenol Corp, Starbucks Corp, Eli Lilly and Co, NetApp Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Pioneer Series Trust Xi.
Merck’s (MRK) COVID Pill Gets FDA Nod for Emergency Use
Fri, 24 Dec 2021 17:38:05 +0000
Merck’s (MRK) oral antiviral molnupiravir secures the FDA-authorized emergency use tag in treating mild-to-moderate COVID-19 in adults for whom other FDA-approved COVID treatments are unsuitable.
Biogen’s (BIIB) Alzheimer’s Disease Drug Gets FDA Fast Track Tag
Fri, 24 Dec 2021 17:22:05 +0000
Biogen (BIIB) receives a fast track designation from the FDA for lecanemab to treat Alzheimer’s disease.
Follow Us on Facebook